Sirolimus-eluting or everolimus-eluting stents for coronary artery disease: 5-year outcomes of the randomised BIOFLOW-IV trial.
作者信息
Slagboom Ton, Toelg Ralph, Witzenbichler Bernhard, Haude Michael, Masotti Monica, Ruiz Salmeron Rafael, Witkowski Adam Ryszard, Uematus Masaaki, Takahashi Akihiko, Waksman Ron, Saito Shigeru
机构信息
Cardiology Unit, OLVG, Amsterdam, the Netherlands.
Herzzentrum, Segeberger Kliniken, Bad Segeberg, Germany.
出版信息
EuroIntervention. 2023 Feb 20;18(14):1197-1200. doi: 10.4244/EIJ-D-22-00526.
Abstract
摘要
相似文献
1
Sirolimus-eluting or everolimus-eluting stents for coronary artery disease: 5-year outcomes of the randomised BIOFLOW-IV trial.西罗莫司洗脱支架或依维莫司洗脱支架治疗冠状动脉疾病：随机BIOFLOW-IV试验的5年结果
EuroIntervention. 2023 Feb 20;18(14):1197-1200. doi: 10.4244/EIJ-D-22-00526.
2
Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial.冠状动脉血运重建患者中应用超薄可生物吸收聚合物西罗莫司洗脱支架与薄型持久聚合物依维莫司洗脱支架（BIOFLOW V）：一项随机试验
Lancet. 2017 Oct 21;390(10105):1843-1852. doi: 10.1016/S0140-6736(17)32249-3. Epub 2017 Aug 26.
3
Ultrathin Bioresorbable-Polymer Sirolimus-Eluting Stents Versus Thin Durable-Polymer Everolimus-Eluting Stents for Coronary Revascularization: 3-Year Outcomes From the Randomized BIOFLOW V Trial.超薄生物可吸收聚合物西罗莫司洗脱支架与薄型持久聚合物依维莫司洗脱支架在冠状动脉血运重建中的比较：随机 BIOFLOW V 试验 3 年结果。
JACC Cardiovasc Interv. 2020 Jun 8;13(11):1343-1353. doi: 10.1016/j.jcin.2020.02.019.
4
Ultrathin-strut, biodegradable-polymer, sirolimus-eluting stents versus thin-strut, durable-polymer, everolimus-eluting stents for percutaneous coronary revascularisation: 5-year outcomes of the BIOSCIENCE randomised trial.超薄支架、可生物降解聚合物、西罗莫司洗脱支架与薄支架、耐用聚合物、依维莫司洗脱支架经皮冠状动脉血运重建：BIOSCIENCE 随机试验 5 年结果。
Lancet. 2018 Sep 1;392(10149):737-746. doi: 10.1016/S0140-6736(18)31715-X. Epub 2018 Aug 28.
5
Comparison of Ultrathin, Bioresorbable-Polymer Sirolimus-Eluting Stents and Thin, Durable-Polymer Everolimus-Eluting Stents in Calcified or Small Vessel Lesions.超薄生物可吸收聚合物西罗莫司洗脱支架与薄型耐用聚合物依维莫司洗脱支架在钙化或小血管病变中的比较。
Circ Cardiovasc Interv. 2020 Sep;13(9):e009189. doi: 10.1161/CIRCINTERVENTIONS.120.009189. Epub 2020 Sep 8.
6
Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents: BIOFLOW V Final 5-Year Outcomes.超亲生物可吸收聚合物西罗莫司洗脱支架与持久性聚合物依维莫司洗脱支架比较：BIOFLOW V 研究 5 年最终结果。
JACC Cardiovasc Interv. 2022 Sep 26;15(18):1852-1860. doi: 10.1016/j.jcin.2022.07.027.
7
Impact of Coronary Calcification on Clinical Outcomes After Implantation of Newer-Generation Drug-Eluting Stents.新型药物洗脱支架植入术后冠状动脉钙化对临床结局的影响。
J Am Heart Assoc. 2021 Jun 15;10(12):e019815. doi: 10.1161/JAHA.120.019815. Epub 2021 May 29.
8
Subgroup Analysis Comparing Ultrathin, Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin, Durable Polymer Everolimus-Eluting Stents in Acute Coronary Syndrome Patients.急性冠状动脉综合征患者中比较超薄可降解聚合物西罗莫司洗脱支架与薄型持久聚合物依维莫司洗脱支架的亚组分析
Circ Cardiovasc Interv. 2018 Oct;11(10):e007331. doi: 10.1161/CIRCINTERVENTIONS.118.007331.
9
Five-year outcomes from a trial of three limus-eluting stents with different polymer coatings in patients with coronary artery disease: final results from the ISAR-TEST 4 randomised trial.一项针对冠心病患者使用三种不同聚合物涂层雷帕霉素洗脱支架的试验的五年结果：ISAR-TEST 4随机试验的最终结果
EuroIntervention. 2016 Mar;11(12):1372-9. doi: 10.4244/EIJY14M11_02.
10
Ultrathin bioresorbable polymer sirolimus-eluting stents in US patients undergoing coronary revascularization: 1-Year outcomes from the BIOFLOW VII trial.美国患者经冠状动脉血运重建术应用超薄生物可吸收聚合物西罗莫司洗脱支架：BIOFLOW VII 试验 1 年结果。
Catheter Cardiovasc Interv. 2023 Sep;102(3):464-471. doi: 10.1002/ccd.30783. Epub 2023 Jul 26.
引用本文的文献
1
Long-Term (5-Years) Outcomes of Current Drug-Eluting Stents in Percutaneous Coronary Intervention: A Network Meta-Analysis of Randomized Controlled Trials.经皮冠状动脉介入治疗中当前药物洗脱支架的长期（5年）疗效：随机对照试验的网状Meta分析
Catheter Cardiovasc Interv. 2025 Aug;106(2):1196-1211. doi: 10.1002/ccd.31668. Epub 2025 Jun 5.
2
Randomized Clinical Trial Comparing Bare-Metal Stents Plus Colchicine Versus Drug-Eluting Stents for Preventing Adverse Cardiac Outcomes: Three-Year Follow-Up Results of the ORal Colchicine in Argentina (ORCA) Trial.比较裸金属支架联合秋水仙碱与药物洗脱支架预防不良心脏结局的随机临床试验：阿根廷口服秋水仙碱（ORCA）试验的三年随访结果
J Clin Med. 2025 Apr 22;14(9):2871. doi: 10.3390/jcm14092871.
3
Comparative effectiveness of ultrathin vs. standard strut drug-eluting stents: insights from a large-scale meta-analysis with extended follow-up.超小径药物洗脱支架与标准支架的比较效果：一项具有延长随访的大规模荟萃分析的见解。
Eur J Med Res. 2024 Jul 27;29(1):388. doi: 10.1186/s40001-024-01949-7.
4
Second-generation everolimus-eluting intracoronary stents: a comprehensive review of the clinical evidence.第二代依维莫司洗脱冠状动脉内支架：临床证据的综合评价。
Future Cardiol. 2024;20(3):103-116. doi: 10.2217/fca-2023-0092. Epub 2024 Jan 31.
5
High Non-Cardiac Death Incidence Should Be a Limitation of Drug-Eluting Stents Implantation? Insights from Recent Randomized Data.高非心脏性死亡发生率应成为药物洗脱支架植入的限制因素吗？来自近期随机数据的见解。
Diagnostics (Basel). 2023 Apr 2;13(7):1321. doi: 10.3390/diagnostics13071321.
Zotero 插件